RLAY   $9.91  -0.90% Market Closed After Close 9.99 0.81%

Relay Therapeutics, Inc.
Total Cash 688.41M
totalCashPerShare 5.142
EBITDA -367.86M
Total Debt 51.10M
quickRatio 15.284
currentRatio 15.636
Total Revenue 35.21M
debtToEquity 7.495
Revenue/Share 0.276
ROA -0.26906002
ROE -0.43278998
grossProfits
freeCashflow -165.57M
operatingCashflow -280.74M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -10.60458
profitMargins 0.0
enterpriseValue 159.33M
forwardPE -1.9904459
floatShares 101.56M
sharesOutstanding 162.46M
sharesShort 11.86M
sharesShortPriorMonth 9.92M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.80%
Short Ratio help_outline 6.16%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 5.113
Price To Book help_outline 1.22
earningsQuarterlyGrowth
netIncomeToCommon -322.83M
trailingEps -2.52%
forwardEps -3.14%
enterpriseToEbitda -0.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.77 3Q 2024
institutionsCount 257
lastUpdated Nov. 7, 2024, 3:18 a.m.